Denali Therapeutics Inc.

Denali Therapeutics develops medicines for diseases that damage the brain and nervous system, particularly Parkinson's disease, Alzheimer's disease, and rare genetic disorders that affect how the body breaks down and stores certain substances. The company is testing multiple drug candidates in clinical trials, including treatments for conditions like Huntington's disease, frontotemporal dementia, and various lysosomal storage diseases such as Pompe disease and Hunter Syndrome. Many of their drugs use a technology platform called Enzyme TransportVehicle, which is designed to help medicines reac...